Clinical Trial Update: Phenotyping and Characterization of wtATTR-CM (TRACE 1)

View source ↗

Summary

Clinical trial TRACE 1 is a recruiting study that aims to phenotype and characterize wild-type transthyretin amyloid cardiomyopathy in transthyretin amyloidosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy
• Transthyretin Amyloidosis

Snippet

Sponsor: Steen Hvitfeldt Poulsen | Conditions: Transthyretin Amyloidosis, Transthyretin Amyloid Cardiomyopathy | Status: RECRUITING